Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy, Safety, and Immunogenicity of V-01 COVID-19 Vaccine in Adults
NCT05096845Phase 3Unknown
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Aug 2021
- Primary completion
- Feb 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of V-01 in coronavirus disease 2019 (COVID-19), sponsored by Livzon Pharmaceutical Group Inc.. Status: unknown.
02
Drugs
V-01
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05096845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096845.